期刊文献+

减少肺癌螺旋断层放疗计划低剂量区体积的研究 被引量:3

Pre-clinical study of reducing the low-dose-area of tomotherapy on lung cancer planning
原文传递
导出
摘要 目的 寻求一种在保证治疗计划临床可行的前提下减少正常肺组织低剂量区体积的肺癌螺旋断层放疗(tomotherapy)计划设计方法.方法 选取30例单侧肺内病灶的肺癌患者CT图像,根据对健侧肺采取不挡(对照)、1/4半挡、1/2半挡、半挡、1/4全挡、1/2全挡和全挡7种条件分别设计A、B、C、D、E、F和G共7组治疗计划,分析各组方案靶区的剂量学参数差异和减少双肺低剂量区(V5~V10)体积的优劣.结果 与A组比较,B、C、D、E组对靶区影响较小,剂量学参数差异均无统计学意义;F组靶区的中位剂量和平均剂量增加,均值在0.5 Gy以内;G组对靶区影响较大,适形度较差.除B组外,其余各组均能减少双肺低剂量区体积(V5:8.06% ~ 45.26%;V10:6.21% ~33.95%);半挡组可减少双肺V20体积(1.71% ~3.78%),全挡组增加了双肺V20体积(2.07% ~5.07%).各组的单次治疗时间均有一定程度的增加(8.51% ~79.22%).结论 对健侧肺半挡可以有效减少双肺低剂量区体积,临床计划设计时可以结合单次治疗时间和患者的耐受状况加长半挡健侧肺的弧度;对部分健侧肺全挡条件较半挡更能有效减少双肺低剂量区体积,但全挡时弧度不宜超过健侧肺弧度的1/2. Objective To seek a optimization method for lung cancer planning with Helical TomoTherapy for reducing the low dose area of total lung.Methods CT images of thirty patients with unilateral lung cancer were selected.Seven plans (Groups A,B,C,D,E,F and G) were generated for each patient using an identical optimization procedure with the conditions that implemented contralateral lung with unblocked (control group),1/4 directional block,1/2 directional block,directional block,1/4 complete block,1/2 complete block and complete block,respectively.The benefits in different schemes of reducing the low dose area of normal lung tissue were estimated,in order to provide a reference treatment plan scheme in clinical.Results Groups B,C,D and E had less influence on the target than that of group A.And there were no statistical difference between the target dosimetric parameters.The median dose and average dose of group F were increased within 0.5 Gy.The conformal index of group G had great influence on the target.The low dose area of total lung were reduced effectively in Groups C,D,E,F and G,the average decrease of V5 and V10 was 8.06%-45.26% and 6.21%-33.95%,respectively.The V20 decreased by 1.71%-3.78% in directional block group,while V20 increased in complete block group (2.07%-5.07%).The single treatment time was increased by 8.51%-79.22%.Conclusions The results showed that the low dose area of total lung was higher for the plan without any block limitation.It could reduce the low dose area of total lung with directional block.We should lengthen the blocking arc of contralateral lung with directional block based on the fractional treatment time and the patient's physical condition.A certain arc of contralateral lung with complete block could effectively reduce low dose area.When complete block was used,it is suggested that the arc was no more than half of the contralateral lung.
出处 《中华放射医学与防护杂志》 CAS CSCD 北大核心 2015年第6期433-436,共4页 Chinese Journal of Radiological Medicine and Protection
基金 民政部“十一五”期间部级老年学研究项目(民人教科字[2008]47-2.32) 北京市自然科学基金(7132211)
关键词 肺癌 螺旋断层放射治疗 治疗计划 低剂量区 Lung cancer Tomotherapy Treatment plan Low-dose-area
  • 相关文献

参考文献10

  • 1石健,王强,王冬青,刘洪付.固定野调强放疗对局部晚期肺癌放射性肺炎的影响[J].中华放射医学与防护杂志,2012,32(6):633-634. 被引量:2
  • 2Song GH, Pyo H, Moon SH, et al. Treatment-related pneumonitis and acute esophagitis in non-small cell lung cancer patients treated with chemotherapy and helical tomotherapy[J]. Int J Radiat Oncol Biol Phys, 2010, 78(3): 651-658.
  • 3Jo I, Kay C, Kim J, et al. Significance of low-dose radiation distribution in development of radiation pneumonitis after helical-tomotherapy-based hypofractionated radiotherapy for pulmonary metastases[J]. J Radiat Res, 2014, 55(1): 105-112.
  • 4van der Geld YG, van Triest B, Verbakel WFAR, et al. Evaluation of four-dimensional computed tomography-based intensity-modulated and respiratory-gated radiotherapy techniques for pancreatic carcinoma[J]. Int J Radiat Oncol Biol Phys, 2008,72(4): 1215-1220.
  • 5Paddick I. A simple scoring ratio to index the conformity of radiosurgical treatment plans[J]. J Neurosurg, 2000, 93(Suppl 3): 219-222.
  • 6Yang J, Amini A, Williamson R, et al. Automatic contouring of brachial plexus using a multi-atlas approach for lung cancer radiation therapy[J]. Pract Radiat Oncol, 2013, 3(4): e139-e147.
  • 7Li HQ, Wang YJ, Li J, et al. The application of gamma stereotactic body radiation therapy in stage I/II non-small-cell lung cancer. Promising and encouraging outcome[J]. Saudi Med J, 2013, 34 (11): 1139-1144.
  • 8Kissick MW, Mo XH, McCall K, et al. A phantom model demonstration of tomotherapy dose painting delivery, including managed respiratory motion without motion management[J]. Phys Med Biol, 2010, 55 (10): 2983-2995.
  • 9Kissick MW, Flynn RT, Westerly DC, et al. On the impact of longitudinal breathing motion randomness for tomotherapy delivery[J]. Phys Med Biol, 2008, 53 (18): 4855-4873.
  • 10Qiu J, Liu ZK, Yang B, et al. Low-dose-area-constrained helical tomotherapy-based whole breast radiotherapy and dosimetric comparison with tangential field-in-field IMRT[J]. Biomed Res Int, 2013,2013: 513708.

二级参考文献15

  • 1Murshed H, Liu HH, Liao Z, et al. Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell tung cancer. Int J Radiat Oncol Biol Phys ,2004,58 (4) : 1258-1267.
  • 2Liu HH, Wang X, Dong L, et al. Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys, 2004, 58(4) :1268-1279.
  • 3Claude L, Perol D, Ginestet C, et al. A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis. Radiother Onco1,2004,71 (2) : 175-181.
  • 4Yom SS, Liao Z, Liu HH, et al. Initial evaluation of treatment- related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity- modulated radiotherapy. Int J Radiat Oncol Biol Phys,2007,68 ( 1 ) : 94-102.
  • 5Wang S, Liao Z, Wei X, et al. Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis(TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT). Int J Radiat Oncol Biol Phys, 2006,66 (5) : 1399-1407.
  • 6Dang J, Li G, Lu X, et al. Analysis of related factors associated with radiation pneumonitis in patients with locally advanced non- small-cell lung cancer treated with three-dimensional conformal radiotherapy. J Cancer Res Clin Oncol, 2010, 136 (8): 1169-1178.
  • 7Moreno M, Aristu J, Ramos LI, et al radiatlon-induced pulmonary toxicity Predictive factors for after three-dimensional conformal chemoradiation in locally advanced non-small-cell lung cancer. Clin Transl Oncol, 2007, 9(9) :596-602.
  • 8Salama JK, Stinchcombe TE, Gu L, et al. Pulmonary toxicity in stage Ⅲ non-Small cell lung cancer patients treated with high- dose (74 Gy) 3-dimensional conformal thoracic radiotherapy and concurrent chemotherapy following induction chemotherapy: a secondary analysis of cancer and leukemia group B (CALGB) trial 30105. Int J Radiat Oncol Biol Phys, 2011, 81 (4): e269-274.
  • 9Liao ZX, Komaki RR, Thames HD Jr, et al. Influence of technologic advances on outcomes in patients with unresectable, locally advanced non-small-cell lung cancer receiving concomitant chemoradiotherapy. Int J Radiat Oncol Biol Phys,2010,76(3) : 775-781.
  • 10Vogelius IS, Westerly DC, Cannon GM, et al. Intensity- modulated radiotherapy might increase pneumonitis risk relative to three-dimensional conformal radiotherapy in patients receiving combined chemotherapy and radiotherapy: a modeling study of dose dumping. Int J Radiat Oneol Biol Phys, 2011,80 (3) : 893 -899.

共引文献1

同被引文献28

引证文献3

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部